Clinical Trials for Innovative Therapies

Explore 9 clinical trials worldwide

Showing 1-9 of 9 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Innovative Therapies

Clinical Trials (9)

NCT06722716
Study of Pneumococcal Carriage in RSV Bronchiolitis in Infants Aged 6 to 18 Months
N/ANot yet recruiting
120 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2026
1 condition3 sponsors1 location
NCT05745714
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
PHASE1/PHASE2Recruiting
26 participants
Started: Oct 1, 2025 · Completed: Feb 2, 2032
5 conditions4 sponsors33 locations
NCT05751044
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
PHASE1/PHASE2Recruiting
26 participants
Started: Oct 1, 2025 · Completed: Feb 1, 2032
5 conditions4 sponsors33 locations
NCT06161285
Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants
N/ARecruiting
120 participants
Started: Dec 6, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors3 locations
NCT05658640
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
PHASE1/PHASE2Recruiting
26 participants
Started: Nov 14, 2023 · Completed: Apr 1, 2029
5 conditions4 sponsors36 locations
NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
PHASE3Recruiting
409 participants
Started: Sep 29, 2022 · Completed: Sep 30, 2031
2 conditions4 sponsors42 locations
NCT04258943
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia
PHASE1/PHASE2Active, not recruiting
60 participants
Started: Jul 6, 2020 · Completed: Jul 31, 2028
4 conditions5 sponsors59 locations
NCT04106219
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
PHASE1Active, not recruiting
71 participants
Started: Jun 11, 2020 · Completed: Aug 31, 2026
1 condition3 sponsors17 locations
NCT03793478
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
PHASE1/PHASE2Active, not recruiting
65 participants
Started: Aug 15, 2018 · Completed: May 1, 2027
1 condition3 sponsors27 locations